Anticoagulation with heparin The art of simplicity even in patients on dialysis.
Jorge A BelardiMariano AlbertalPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
In current PCI practice, anticoagulation with either bivalirudin or unfractionated heparin in patients with ACS share comparable efficacy and safety. Nonetheless, their individual performance in patients on dialysis remains unclear. This observational PCI study reported in-hospital clinical outcome in patients on dialysis undergoing PCI according to drug regimen: bivalirudin versus heparin. Similar clinical outcome was observed with both drug regimens.
Keyphrases
- end stage renal disease
- chronic kidney disease
- peritoneal dialysis
- newly diagnosed
- acute coronary syndrome
- ejection fraction
- venous thromboembolism
- percutaneous coronary intervention
- atrial fibrillation
- healthcare
- coronary artery disease
- emergency department
- growth factor
- antiplatelet therapy
- adverse drug
- hiv infected